The Scientist

» clinical trials

Most Recent

image: Not All Stem Cells Created Equal

Not All Stem Cells Created Equal

By | July 2, 2014

Compared to induced pluripotent stem cells generated from somatic cells, stem cells created by nuclear transfer appear to be closer to the genetic state of embryonic cells.

1 Comment

image: Accidental Orgasms

Accidental Orgasms

By | July 1, 2014

Meet the researcher struggling to gain approval for his medical device, which was originally designed to relieve back pain, but turned out to be an orgasm inducer.

1 Comment

image: That Loving Feeling

That Loving Feeling

By | July 1, 2014

There are no FDA-approved drugs to treat low sexual desire in women, but not for lack of trying.

1 Comment

image: Medical Marijuana: Where’s the Data?

Medical Marijuana: Where’s the Data?

By | June 30, 2014

As more states legalize therapeutic cannabis, some caution against overprescribing the drug, the benefits of which have not been rigorously tested in clinical trials.

2 Comments

image: Week in Review: June 16–20

Week in Review: June 16–20

By | June 20, 2014

Early Neanderthal evolution; developing antivirals to combat polio; the mouth and skin microbiomes; insect-inspired, flight-stabilizing sensors

0 Comments

image: Opinion: Thwarting Medical Tourism

Opinion: Thwarting Medical Tourism

By | June 17, 2014

It’s time to take a strong stance against unregistered cellular therapies, which can undermine legitimate research efforts.

0 Comments

image: To Finish Off Polio

To Finish Off Polio

By | June 17, 2014

Along with vaccination, antiviral drugs could play a key role in the eradication of poliovirus, but it’s unclear whether today’s candidate therapies will withstand the challenges of the clinic.

0 Comments

image: EMA Gearing Up for Transparency

EMA Gearing Up for Transparency

By | June 16, 2014

The European Medicines Agency is preparing for a new policy that will release rarely-seen clinical trial reports for independent scrutiny.  

0 Comments

image: Geron hESC Trial to Resume?

Geron hESC Trial to Resume?

By | May 27, 2014

Nearly three years after Geron shuttered its stem cell program, BioTime receives funding to relaunch a Phase 1 trial for spinal cord injury.

0 Comments

image: NIH Accused of Interfering with Ethics Probe

NIH Accused of Interfering with Ethics Probe

By | May 21, 2014

A watchdog group claims that the federal agency improperly influenced the investigation of a study involving the treatment of preterm infants.

3 Comments

Popular Now

  1. Decoding the Tripping Brain
  2. Tattoo Ink Nanoparticles Persist in Lymph Nodes
    The Nutshell Tattoo Ink Nanoparticles Persist in Lymph Nodes

    Analysis of the bodies of deceased individuals can’t determine what effect these tattoo remnants have on lymph function, but researchers suggest dirty needles aren’t the only risk of the age-old practice.

  3. Do Microbes Trigger Alzheimer’s Disease?
  4. Metabolomics Data Under Scrutiny
    Daily News Metabolomics Data Under Scrutiny

    Out of 25,000 features originally detected by metabolic profiling of E. coli, fewer than 1,000 represent unique metabolites, a study finds.

AAAS